The global thalassemia market size was valued at USD 850.0 million in 2023 and is projected to grow from USD 1056.8 million in 2026 to USD 1,430.1 million by 2030, at a CAGR of 7.7% from 2024 to 2030. The market in North America dominated with a revenue share of 42.8% in 2023. This growt... Read More »
September 2024The global primary immunodeficiency disorders market size was valued at USD 7.2 billion in 2023 and is projected to grow from USD 8.7 billion in 2026 to USD 11.1 billion by 2030, at a CAGR of 6.5% from 2024 to 2030. The market in North America dominated with a revenue share of 45.4% in 2... Read More »
September 2024The global pharmerging market size was valued at USD 1,730.0 billion in 2023 and is projected to grow from USD 1,877.4 billion in 2026 to USD 2,077.3 billion by 2030, at a CAGR of 2.6% from 2024 to 2030. The North America held the largest share of 42.8% of the global market in 2023. This... Read More »
September 2024The global doxorubicin market size was estimated at USD 989.6 million in 2023 and is projected to reach USD USD 1.53 billion by 2030, growing at a CAGR of 6.6% from 2024 to 2030. Doxorubicin, a potent chemotherapy drug in the anthracycline class, has established a significant presence in... Read More »
August 2024The global superdisintegrants market size was valued at USD 536.2 million in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. This growth is attributed to several factors, including the expansion of the generics market, which heavily utilizes orally disintegrating... Read More »
August 2024The global acute lymphocytic leukemia therapeutics market size was valued at USD 3.1 billion in 2023 and is projected to grow from USD 3.8 billion in 2026 to USD 4.9 billion by 2030, at a CAGR of 7.0% from 2024 to 2030. The market in North America dominated with a revenue share of 37.6% ... Read More »
August 2024The global smoking cessation and nicotine de-addiction market size was valued at USD 25.5 billion in 2023 and is projected to grow from USD 34.3 billion in 2026 to USD 50.9 billion by 2030, at a CAGR of 10.4% from 2024 to 2030. The market in North America dominated with a revenue share o... Read More »
August 2024The global bipolar disorder market size was valued at USD 4.88 billion in 2023 and is projected to grow at a CAGR of 2.7% from 2024 to 2030. The major factors responsible for the growth of this market are the rising prevalence of bipolar disorder and the increase in government investment... Read More »
August 2024The global pediatric vaccines market size was valued at USD 44.87 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. This is due to increased awareness of the benefits of vaccines worldwide, resulting in higher demand for childhood vaccines. ... Read More »
August 2024The global type 2 diabetes mellitus treatment market size was valued at USD 57.5 billion in 2023 and is projected to grow from USD 70.3 billion in 2026 to USD 91.9 billion by 2030, at a CAGR of 6.9% from 2024 to 2030. The market in North America dominated with a revenue share of 39.5% in... Read More »
August 2024The global catastrophic antiphospholipid syndrome market size was valued at USD 4.4 billion in 2023 and is projected to grow from USD 6.0 billion in 2026 to USD 9.0 billion by 2030, at a CAGR of 10.7% from 2024 to 2030. The market in North America dominated with a revenue ... Read More »
August 2024The global blastic plasmacytoid dendritic cell neoplasm market size was valued at USD 127.6 million in 2023 and is projected to grow from USD 159.4 million in 2026 to USD 214.3 million by 2030, at a CAGR of 7.7% from 2024 to 2030. The market in North America dominated with a revenue shar... Read More »
August 2024The global angina pectoris drugs market size was estimated at USD 11.37 billion in 2023 and is projected to reach USD 15.71 billion by 2030, growing at a CAGR of 4.0% from 2024 to 2030. Advancements in personalized cardiovascular medicine and novel drug delivery systems are driving market expansion. ... Read More »
August 2024The global thyroid gland disorder treatment market size was valued at USD 2.22 billion in 2023 and is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising incidences of hypothyroidism and hyperthyroidism globally, driven by factors such as the aging population, autoimmune di... Read More »
August 2024The global pharmaceuticals cleaning validation market size was valued at USD 18.13 billion in 2023 and is projected to grow at a CAGR of 6.7% from 2024 to 2030. The growing focus on patient health and safety is a major driver for market expansion. This has resulted in strict regulations ... Read More »
August 2024The global hairy cell leukemia treatment market size was valued at USD 102.1 million in 2023 and is projected to grow from USD 119.5 million in 2026 to USD 147.6 million by 2030, at a CAGR of 5.4% from 2024 to 2030. The market in North America dominated with a revenue share of 40.0% in 2... Read More »
August 2024The global breast adenocarcinoma treatment market size was valued at USD 23.3 billion in 2023 and is projected to grow from USD 30.3 billion in 2026 to USD 42.9 billion by 2030, at a CAGR of 9.1% from 2024 to 2030. The market in North America dominated with a revenue share of 39.5% in 20... Read More »
August 2024The global crohn's disease therapeutics market size was valued at USD 13.20 billion in 2023 and is projected to grow at a CAGR of 2.7% from 2024 to 2030. The increased incidence of Crohn’s disease in patients in several countries has triggered the need for therapeutics. Furthe... Read More »
August 2024The global estrogen receptor positive breast cancer treatment market size was valued at USD 19.8 billion in 2023 and is projected to grow from USD 24.9 billion in 2026 to USD 33.7 billion by 2030, at a CAGR of 7.9% from 2024 to 2030. The market in North America dominated with a revenue share of 39.5% in 2023. Severa... Read More »
August 2024The global myelodysplastic syndrome drugs market size was estimated at USD 2.88 billion in 2023 and is projected to reach USD 5.28 billion by 2030, growing at a CAGR of 9.1% from 2024 to 2030. Myelodysplastic syndrome increases with age, mostly occurring after the age of 65. The market is primarily driven by a rise ... Read More »
August 2024